The purpose of this study is to determine the safety and efficacy of three concentrations of ZK 245186 ointment and vehicle on increasing body surface areas for the treatment of atopic dermatitis and to obtain dose-response information for the three concentrations.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
64
Once daily topical non-occlusive application for up to 4 weeks
Once daily topical non-occlusive application for up to 4 weeks
PAREXEL International (Bloemfontein)
Bloemfontein, South Africa
PAREXEL International (George)
George, South Africa
PAREXEL International (Port Elizabeth)
Newton Park, South Africa
Assessment of the severity of atopic dermatitis at target lesion, based on clinical signs of inflammation
Time frame: up to 4 weeks
Investigator's Global Assessment of target area
Time frame: up to 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.